Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

2,539 Results (Page 66 of 127)
- Relevance
  Sort by

Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

 Report
December 2023
137 Pages
Global

From

€2175EUR$2,475USD£1,876GBP

€4349EUR$4,950USD£3,752GBP

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

 Report
March 2025
1048 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Active Pharmaceutical Ingredients Market by Therapeutic Application, Molecule Type, Source, Route Of Administration, Application, Product Category - Global Forecast to 2030

 Report
May 2025
185 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
417 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
4115 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
1834 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
74 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Psoriatic Arthritis Treatment - Global Strategic Business Report

 Report
July 2025
452 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Sciatica Treatment - Global Strategic Business Report

 Report
July 2025
380 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Retinal Drugs Market 2025-2029

 Report
April 2025
217 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Bipolar Disorder Therapeutics Market Report 2025

 Report
January 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Anticoagulants - Global Strategic Business Report

 Report
July 2025
196 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1755EUR$1,997USD£1,514GBP

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6985EUR$7,950USD£6,026GBP

Artificial Intelligence in Oncology Market Industry Trends and Global Forecasts to 2035, by Type of Cancer, Type of End-Users and Key Geographical Regions

 Report
February 2025
220 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

 Report
February 2025
315 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Skeletal Dysplasia - Global Strategic Business Report

 Report
July 2025
378 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

 Report
January 2025
363 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

BREYANZI Drug Insight and Market Forecast - 2032

 Drug Pipelines
November 2023
30 Pages
Global

From

€2416EUR$2,750USD£2,084GBP

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
June 2021
193 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

2,539 Results (Page 66 of 127)
- 1
- 64
- 65
- 66
- 67
- 68

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.